loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Pasireotide Pamoate

    Menu

    Pasireotide Pamoate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203255 / DOSAGE - FOR SUSPENSION;INTRAMUSCULAR - EQ 30MG BASE/VIAL

    Inactive Ingredients

    Ingredient Name
    Novartis Pharmaceuticals Corporation
    CARBOXYMETHYLCELLULOSE SODIUM(K679OBS311)
    MANNITOL(3OWL53L36A)
    POLOXAMER 188(LQA7B6G8JG)
    POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 12000 MW)(WE369X5600)
    POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 63000 MW)(QD923V64H3)
    WATER(059QF0KO0R)